Xin Hua Cai Jing·2025-11-26 12:46Core Insights - Alibaba Health reported a revenue of RMB 16.697 billion for the six months ending September 30, 2025, representing a year-on-year growth of 17% [2] - The company achieved a gross profit of RMB 4.184 billion, up 18.4% year-on-year, and a net profit of RMB 1.266 billion, which increased by 64.7% [2] - Adjusted net profit reached RMB 1.356 billion, reflecting a year-on-year growth of 38.7% [2] Financial Performance - Revenue for the self-operated pharmacy business was RMB 14.38 billion, marking an 18.6% increase year-on-year [2] - The number of active users and annual ARPU for the self-operated business continued to grow, with SKUs increasing by 98.8% to 1.61 million [2] Strategic Initiatives - Alibaba Health is focusing on deepening its investment in the medical AI sector and enhancing its strategic layout in the toB medical verticals [2][4] - The company has partnered with leading pharmaceutical brands to provide comprehensive services from drug launch to patient education and online consultations [3] - The integration of online and offline healthcare services has been emphasized, with over 250,000 healthcare professionals providing online consultation services [3] AI and Technology Development - Alibaba Health is increasing resource investment in medical AI applications to improve user experience and search conversion efficiency [4] - The company aims to explore applications in serious medical fields, enhancing the evidence-based capabilities of its models in clinical decision-making and research [4]